Alan Shuldiner, MD
Vice President, Regeneron Genetics Center, Regeneron
1. To describe the challenges of finding safe and effective therapeutic targets and the promise of applying human genetics to the challenge.
2. To describe the approaches of exome-wide and phenome-wide association analysis toward identifying novel therapeutic targets, unanticipated indications, and potential on-target side effects.
3. To describe how patient genomic information may be incorporated into clinical care toward the goal of precision medicine.
A live webcast sponsored by:
The Rockefeller University Hospital Center for Clinical and Translational Science and Clinical Directors Network, Inc. (CDN)
Wednesday, November 15th, 2017 12:00 PM – 1:00 PM EST
This activity has been reviewed and approved for up to 1.0 Prescribed credit(s) by the American Academy of Family Physicians (AAFP). Enduring credits valid until November 15, 2018.